Company Analysis Zhaoke Ophthalmology Limited
1. Summary
Advantages
- The stock's return over the last year (88.89%) is higher than the sector average (38.18%).
Disadvantages
- Price (2.72 HK$) is higher than fair price (2.4 HK$)
- Dividends (0%) are below the sector average (5.88%).
- Current debt level 5.88% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-12.03%) is lower than the sector average (ROE=4.33%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Zhaoke Ophthalmology Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -8.4% | -8% | -1.5% |
| 90 days | 81.3% | 19.4% | -0.7% |
| 1 year | 88.9% | 38.2% | 30.5% |
6622 vs Sector: Zhaoke Ophthalmology Limited has outperformed the "Healthcare" sector by 50.71% over the past year.
6622 vs Market: Zhaoke Ophthalmology Limited has outperformed the market by 58.37% over the past year.
Slightly volatile price: 6622 is more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: 6622 with weekly volatility of 1.71% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2.72 HK$) is higher than the fair price (2.4 HK$).
Price is higher than fair: The current price (2.72 HK$) is 11.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (2.06) is lower than that of the sector as a whole (37.31).
P/E vs Market: The company's P/E (2.06) is lower than that of the market as a whole (44.35).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.3268) is lower than that of the sector as a whole (1.95).
P/BV vs Market: The company's P/BV (0.3268) is lower than that of the market as a whole (1.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.96) is higher than that of the sector as a whole (4.81).
P/S vs Market: The company's P/S indicator (8.96) is higher than that of the market as a whole (2.64).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.59) is lower than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.59) is lower than that of the market as a whole (9.93).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -13.47% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-13.47%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.23%).
5.4. ROE
ROE vs Sector: The company's ROE (-12.03%) is lower than that of the sector as a whole (4.33%).
ROE vs Market: The company's ROE (-12.03%) is lower than that of the market as a whole (2.87%).
5.5. ROA
ROA vs Sector: The company's ROA (-10.18%) is lower than that of the sector as a whole (3.1%).
ROA vs Market: The company's ROA (-10.18%) is lower than that of the market as a whole (3.12%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (20.88%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '5.88%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
